The recent congressional hearings held by House and Senate committees are being interpreted as a good indication that bi-partisan support can be mustered to pass legislation that would strengthen FDA oversight of compounders.

FORBES: How The Compounding Scandal Benefits One Drugmaker

Mr. Romney again declines to offer specifics, instead suggesting it can be left to the cooperation of a Congress that could not even pass an economic plan developed by their own bi-partisan panel as a path forward in dire economic times.

FORBES: Reality Check: A Women's View of the Economy on the Eve of the Election